تداخل‌های دارویی
Aliskiren + Canagliflozin
شدت: متوسط
Aliskiren and Canagliflozin: moderate interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
The legacy premise that canagliflozin raises serum potassium is a recognized labeled effect in some patients, particularly with renal impairment, and aliskiren can also raise potassium through renin-angiotensin blockade. Combined use may add to hyperkalemia risk, and both can affect volume status and renal function.
معنای این تداخل به زبان ساده
Aliskiren and Canagliflozin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Aliskiren belongs to Cardiovascular; Canagliflozin belongs to Endocrine.
چرا رخ می‌دهد
Additive effects on potassium: aliskiren reduces aldosterone-mediated potassium excretion while canagliflozin may modestly increase potassium via volume and hemodynamic effects.
اقدام لازم
Monitor serum potassium and renal function after starting the combination, especially in patients with reduced eGFR or diabetes. Reassess if potassium rises or renal function declines.
از داروساز چه بپرسید
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Aliskiren و Canagliflozin، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Canagliflozin
تداخلات دیگر Aliskiren
پرسش‌های متداول
Can I take Aliskiren with Canagliflozin?
MediHelp rates the interaction as moderate. Aliskiren and Canagliflozin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. The legacy premise that canagliflozin raises serum potassium is a recognized labeled effect in some patients, particularly with renal impairment, and aliskiren can also raise potassium through renin-angiotensin blockade. Combined use may add to hyperkalemia risk, and both can affect volume status and renal function.
How serious is the interaction between Aliskiren and Canagliflozin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium and renal function after starting the combination, especially in patients with reduced eGFR or diabetes. Reassess if potassium rises or renal function declines.
What other medicines interact with Canagliflozin?
MediHelp also lists interactions of Canagliflozin with, for example, Amiloride, Amlodipine-benazepril, Amlodipine-hydrochlorothiazide-valsartan. The full list is on the Canagliflozin page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
